Zydus Wellness Limited reported a consolidated net profit of ₹1,279 million for the quarter ended June 30, 2025. The company's revenue from operations stood at ₹8,609 million for the same period. The board of directors approved these unaudited financial results in their meeting held on July 30, 2025.
Consolidated Financial Results for Q1 FY26 (in ₹ Million)
Particulars
June 30, 2025
March 31, 2025
June 30, 2024
Year Ended March 31, 2025
Revenue from operations
8,609
9,131
8,410
27,089
Profit before tax
1,453
1,734
1,516
3,588
Net Profit
1,279
1,719
1,477
3,469
Basic Earnings per share (₹)
20.10
27.01
23.21
54.52
Diluted Earnings per share (₹)
20.10
27.01
23.21
54.52
Financial Performance
Revenue: Revenue from operations increased to ₹8,609 million, compared to ₹8,410 million in the corresponding quarter of the previous year.
Profit Before Tax: Profit before tax stood at ₹1,453 million, slightly lower than ₹1,516 million in the same quarter last year.
Net Profit: Net profit decreased to ₹1,279 million, as against ₹1,477 million in the corresponding quarter of the previous year.
Additional Items
Exceptional Items: Exceptional items include a profit from the sale of the "Equals Two" brand by Zydus Wellness Products Limited to Zydus Lifesciences Limited, amounting to ₹59 million.
Tax Expense: Deferred tax expense for the quarter includes a net reversal of Minimum Alternate Tax (MAT) credit entitlement amounting to ₹146 million.
Subsidiaries
As of June 30, 2025, the company has the following subsidiaries:
Naturell (India) Private Limited: On July 1, 2025, a special resolution was passed to approve the voluntary liquidation of Naturell (India) Private Limited, with its business undertaking to be distributed to Zydus Wellness Limited.
Standalone Financial Results for Q1 FY26 (in ₹ Million)
